Assertio Therapeutics's total assets for Q2 2025 were $273.78M, a decrease of -4.42% from the previous quarter. ASRT total liabilities were $180.48M for the fiscal quarter, a 1.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.